INUED DISCONTINUED DISCONTINUED DISCON MAKING THE IMPOSSIBLE POSSIBLE CENTER FOR REGENERATIVE MEDICINE

Similar documents
The Role of Adult Stem Cells in Personalized and Regenerative Medicine

Des cellules-souches dans le poumon : pourquoi faire?

From Stem Cell to Any Cell

MAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE

Regenerative Medicine. Speaker Disclosures. What is regenerative medicine? 6/22/2016

Stem Cells Canadian Perspective

Stem cells and motor neurone disease

Patient Handbook on Stem Cell Therapies

The New News in Stem Cell Research Andrés Bratt-Leal, PhD 12/1/2017

STEM CELLS BONE FRACTURE

Scientists have successfully used stem cells to reverse this paralysis. Magnification 0.02

Should Embryonic Stem Cell Research be Permitted to Continue? Over the past few years a debate has been going on over the moral implications of

ANAT 2341 Embryology Lecture 18 Stem Cells

ANAT 3231 Cell Biology Lecture 21 Stem Cells

What Are Stem Cells? Where Are These Stem Cells?

Stem Cell Research and Kidney Disease

NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY:

EMBRYONIC STEM CELL RESEARCH: ALTERNATIVE METHODS & ALZHEIMER S DISEASE

STEM CELLS IN NEUROLOGY ISABELLE COCHRANE MERIT

Stem Cell Services. Driving Innovation for Stem Cell Researchers

Special Report. medicine? Peter Marks, M.D., Ph.D., and Scott Gottlieb, M.D.

5.5. Multicellular Life. Multicellular organisms depend on interactions among different cell types.

STEM CELLS. An Interactive Qualifying Project Report. Submitted to the Faculty of WORCESTER POLYTECHNIC INSTITUTE

Characteristics. Capable of dividing and renewing themselves for long periods of time (proliferation and renewal)

Clip 1: Hip dysplasia Clip 2: Vet-Stem s Dr. Harman

5.5. Multicellular Life. Multicellular organisms depend on interactions among different cell types.

Tissue Engineering and the Brain. Susan Perry Bioengineering Program Lehigh University

Stem Cells: A Primer National Institutes of Health

Insight to Gene Techno Science Co.,Ltd

BIOTECHNOLOGY. Unit 8

Fundamental properties of Stem Cells

PhysicsAndMathsTutor.com. Question Number. Answer Additional guidance Mark. 1(a) 1. reference to stem cells being {totipotent / pluripotent} ;

Stem Cells. Part 1: What is a Stem Cell? STO Stem cells are unspecialized. What does this mean?

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York

Title of Movie: Stem cells: Medical Breakthrough or One Way Ticket to Cloning

Stem Cells for the Future Treatment of Parkinson's Disease

Myeloma Bone Disease Current and Future Treatment. A Publication of The Bone and Cancer Foundation

Nanotechnology and Advanced Materials for more effective Healthcare

Regeneration of spinal cord injury (SCI) : What we know so far. By: Kendra Michaud

RAPAMYCIN. activity 2C. ACTIVITY 2C: Organisms in Research - Card Sort Activity. Organisms in Research (Card Sort) TEACHER SECTION 1.

InVivo Therapeutics. Developing Innovative Products for Spinal Cord Injury

Recent Progress in ips Cell Research and Application

Stem Cell Principle -

The Yale Center for Molecular Discovery. A Core Research Facility at Yale s West Campus

The Future of Health Research: It s in Our Culture

Holland Innovation Network Team Boston: Walter de Wit Julia Knoeff

Fujifilm s Initiatives in Regenerative Medicine

The 3Rs: are Human Stem Cells and Organs on Chip alternatives?

Daily Agenda. Make Checklist: Think Time Replication, Transcription, and Translation Quiz Mutation Notes Download Gene Screen for ipad

Stem cells: The secret to change

DB3230 Midterm 1 11/15/2013 Name:

The Endocrine Society Strategic Plan 2011 (Approved by Council on June 2, 2011) Strategic Plan Overview

Introduction This is an exam style question on stem cells that might be useful towards the end of the topic.

Cloning For Embryonic Stem Cells

leading the way in research & development

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION STAFF WORKING PAPER REPORT ON HUMAN EMBRYONIC STEM CELL RESEARCH

At the conclusion of this lesson you should be able to:

Supplemental Information. Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry. Leigh Turner and Paul Knoepfler

John Gurdon was testing the hypothesis of genomic equivalence or that when cells divide they retain a full genomic compliment.

105 AUSGABE 07 MAI 2014

An Taoiseach Opens New Research Centres to Benefit Frontline Patient Care

NPTEL Biotechnology Tissue Engineering. Stem cells

Stem Cells and Regenerative Medicine

Shivom, the global Genomics-Blockchain Ecosystem The Next Era of Genomics and Healthcare

Understanding the Gene Therapy Market Today

Blue Marble University Biology Course Handbook

Background. Background. Background. Background. Background 3/4/2013

The New IT Organization Disruptor: Consumerization of IT

THE PATH TO PRECISION MEDICINE IN MULTIPLE MYELOMA. themmrf.org

Information and resources for African Americans living with multiple myeloma and their caregivers

PLTW Biomedical Science Medical Interventions Course Outline

With a lot of TLC and ingenuity, Eric Lagasse is growing working livers in lymph nodes. 18 PITTMED

AB Serum. Your Questions Answered

MEDICATION GUIDE RIBAVIRIN TABLETS Rx Only Read this Medication Guide carefully before you start taking ribavirin tablets and read the Medication

Alliance for Regenerative Medicine

Innovating out of Crisis

Stem Cells. for Journalists, Policymakers, and Campaigns

Production Assistance for Cellular Therapies PACT

Cellular Therapies for Skin Disease

Research Strategy Delivering internationally excellent research for a healthy, safe and sustainable society

STEM CELLS. An Interactive Qualifying Project Report. Submitted to the Faculty of WORCESTER POLYTECHNIC INSTITUTE

COVER FEATURE HOW NANOTECHNOLOGY CAN REVOLUTIONIZE MEDICINE

Honors 177 MIDTERM. OncoProbe

Immunogenicity of Stem Cells in Therapeutic Applications. MDPB-Registry meeting nov 25th Stem cell immunogenicity in therapeutic applications

THE PROMISE OF STEM CELLS. UCLA Health David Geffen School of Medicine

Embryonic development, epigenics and somatic cell nuclear transfer - The science and its social implications -

BIOTECHNOLOGY. Understanding the Application

THE NEW WORLD OF CELLULAR HEALING

Stem Cell Applications and Good Manufacturing Practice (GMP) at the UC Davis Institute for Regenerative Cures

Cell and Gene Therapy Catapult preclinical database

15.3 Applications of Genetic Engineering

Transcription:

INUED DISCONTINUED DISCONTINUED DISCON MAKING THE IMPOSSIBLE POSSIBLE CENTER FOR

> SOLUTIONS AND HOPE Millions of people worldwide suffer from deadly diseases, chronic conditions and congenital disorders that today have no cure. Using currently available conventional medical practices, health care workers often can only treat the symptoms of patients whose lives are shortened or permanently altered by heart failure, Alzheimer s disease, spinal-cord injuries, diabetes, and myriad other afflictions. The rise of Regenerative Medicine is transcending traditional treatment limitations and transforming health care. WITH BENEFACTOR SUPPORT, WE ARE HARNESSING NEW DISCOVERIES ABOUT THE BODY S OWN HEALING POWERS. Mayo Clinic s Center for Regenerative Medicine physicians and researchers are developing nextgeneration therapies and surgical procedures to finally defeat the most feared diseases and cure the most intractable conditions. 2 MAKING THE IMPOSSIBLE POSSIBLE MAYO CLINIC CENTER FOR

> REVOLUTIONIZING Mayo Clinic the world s most trusted name in medical research, patient care and education leads the nation in the number of solid organ and bone marrow transplants performed annually. Through its Regenerative Medicine initiative, Mayo Clinic is building on that success to address unmet needs by replacing, rejuvenating, and regenerating cells, tissues, and organs in patients bodies to ensure structural and functional repair. This revolution in health care requires the support of visionary benefactors committed to transforming the future of medicine. Through benefactor generosity, Mayo Clinic will endure as the premier destination at the vanguard of patient care. And the Center for Regenerative Medicine will stand at the forefront in the research and practice of definitive medical and surgical solutions for diseases and conditions that for too long have been considered incurable. The diffusion of this new knowledge and clinical practice will be profound, improving worldwide standards of care, invigorating education across the globe, and eventually extending healthy lifespans for people around the world. > HEALING FROM WITHIN At a time when millions around the globe suffer from pandemics that have no cure, the world stands on the threshold of a new age in health care. Conventional medical standards and practices often fail to address the root causes of chronic conditions such as heart disease, cancer, and diabetes. With its potential restorative powers, Regenerative Medicine is transforming health care by addressing their root causes, offering targeted preventive and curative treatments. MAKING THE IMPOSSIBLE POSSIBLE MAYO CLINIC CENTER MAKING FOR THE IMPOSSIBLE POSSIBLE 3

> MAYO CLINIC PROJECTS SPAN THE SPECTRUM: ACCELERATED CLINICAL TRIALS These ongoing trials are specifically developed for patients with neurodegenerative diseases, heart failure, peripheral vascular disease, congenital heart disease, and kidney disease. GROWING NEW ORGANS Using a patient s own cells, whole new organs, such as the lung, are being reconstructed. And because the cells start with the patient, rejection isn t an issue, which ends the need for a lifetime regimen of immunosuppressant drugs. BIOENGINEERING STEM CELLS One method takes skin cells called fibroblasts and reprograms them into induced pluripotent stem (ips) cells, which can differentiate into virtually any tissue in the body. DEVELOPING INSULIN-PRODUCING CELLS One technique first converts a patient s skin or blood cells into ips cells in the laboratory to produce new glucose-responsive, insulinproducing cells. Once fully optimized, such cells may enable a novel therapy for diabetes. CONSTRUCTING SCAFFOLDS Using donor tissue and biodegradable synthetics, researchers are building bioscaffolds to construct new organs and support regenerative outcomes. DEVELOPING BIOLOGICAL HEART VALVES After cells are removed from a donor heart a process called decellularization the cell-free tissue scaffold that remains is populated with cells derived from the patient. These specially engineered cells regrow within the scaffold, creating a new, patient-specific heart valve that would replace the patient s damaged valve. DEVELOPING SMART STEM CELLS This innovation guides adult stem cells, isolated from the patient s bone marrow or fat, to become another tissue, for example new heart-like tissue or new bone. Through this technique, we have successfully treated patients with heart failure following a heart attack. DEVELOPING PATIENT-SPECIFIC LIVER CELL TRANSPLANTATION With this approach, researchers convert patient cells into ips cells, then into liver-like cells. During the process, gene therapy corrects the underlying defect that caused the disease. Researchers envision transplanting the cells into a bioengineered liver, where they can grow into fully functioning, patientspecific adult liver cells that could be transplanted back into the patient to regenerate the liver. REBUILDING LIMBS Researchers are developing models to study stem cell repopulation of a limb from which all the cells have been removed. Doctors also are reconstructing several hand and facial anomalies, such as those of the nose and ear. 4 MAKING THE IMPOSSIBLE POSSIBLE MAYO CLINIC CENTER FOR

> A NEW VISION FOR HEALTH CARE The medical implications of this work are limitless. We can now imagine providing new blood cells for patients with leukemia, healthy neurons for those afflicted by stroke, Alzheimer s, or Parkinson s, restorative pancreatic cells for people with diabetes, stem cells trained to become new heart tissue, and much more. Where we re going: VALVULAR HEART DISEASE Surgery or valve replacement Populate a scaffold using patient s own cells to build a patient-specific valve AMYOTROPHYIC LATERAL SCLEROSIS (ALS, OR LOU GEHRIG S DISEASE) No current treatment Apply stem cells to restore neural function LUNG FAILURE Transplant organ from donor Grow lung in lab using patient s own cells HEART FAILURE Implant mechanical device to assist damaged heart Inject stem cells harvested from patient to heal damaged tissue PARALYSIS FROM TRAUMA No current treatment Regrow nerves to restore function and sensation LIVER DISEASE Transplant organ from donor Use remaining healthy liver cells to build a patient-specific bioartificial liver TRANSPLANTATION Transplant organ from donor Build a new organ from tissue harvested from the patient s skin DIABETES Insulin maintenance Gene and cell therapy to generate functional beta cells, critical to insulin regulation OSTEONECROSIS OF THE HIP Total hip replacement Hip decompression in which progenitor cells taken from patient s bone marrow are delivered to hipbone to restore function MAKING THE IMPOSSIBLE POSSIBLE MAYO CLINIC CENTER MAKING FOR THE IMPOSSIBLE POSSIBLE 5

> WHAT ROLE DO STEM CELLS PLAY IN? Through a process called differentiation, stem cells have the ability to develop into many types of cells, such as heart cells, brain cells and lung cells. Stem cells are a key component of Regenerative Medicine, as they open the door to new clinical applications that can heal the body from within. At Mayo Clinic, Regenerative Medicine teams are studying a variety of stem cells, especially natural mesenchymal stem cells, bioengineered ips cells and various specialized tissue progenitor cells, which are more specific than stem cells but retain the ability to differentiate into specific types of cells. Each type has unique qualities, with some being more versatile than others. How Mayo Clinic teams acquire and refine stem cell products is revolutionizing the field. Stems cells are derived from various sources, including bone marrow, skin, blood, and fat. In fact, many regenerative therapies under development at Mayo Clinic begin with a patient s own cells, which we program to display unique features to treat the patient s specific disease. A major advantage of these cells is the immune system won t mount an attack (as they do with traditional transplant) because the cells originate with the patient. 6 MAKING THE IMPOSSIBLE POSSIBLE MAYO CLINIC CENTER FOR

> VISIONARY BENEFACTORS ARE CATALYSTS TO THE FUTURE OF Benefactors of the Center of Regenerative Medicine are co-visionaries who help make the once unimaginable a reality. They help fuel pioneering medical research, world-class patient-centered care, and unrivaled educational programs. PHILANTHROPIC SUPPORT IS CRITICAL TO ACCELERATING BREAKTHROUGHS. CURRENTLY, IT TAKES ROUGHLY TWO DECADES FOR PHYSICIANS TO IMPLEMENT CLINICAL RESULTS INTO DAILY PRACTICE. WE CAN T WAIT THAT LONG. PEOPLE NEED HELP NOW. As government continues to reduce funding for research, industry grows increasingly reluctant to fund high-risk, high-reward work that offers no guarantee of profits. But with your help, Mayo Clinic will fast-track the translation of innovations and discoveries into medical practice. And because Regenerative Medicine places a premium on solving the most serious and intractable medical problems today, benefactors will be contributing to discoveries that could immediately improve medical practice and patients lives. Catalyzed through the Center for Regenerative Medicine, an initiative designated as a strategic priority by the Mayo Clinic Board of Governors, the world s finest teams of scientists, engineers, and physicians are spearheading state-of-the-art Regenerative Medicine discovery. With your support, the Center for Regenerative Medicine will drive advances developed at Mayo Clinic nationally and internationally. MAKING THE IMPOSSIBLE POSSIBLE MAYO CLINIC CENTER MAKING FOR THE IMPOSSIBLE POSSIBLE 7

ABOUT THE CENTER FOR > Regenerative Medicine at Mayo Clinic harnesses its collective knowledge, resources, and skills to teach the body to heal from within. This unprecedented science offers patients hope and definitive solutions for devastating diseases and conditions. This top strategic priority at Mayo Clinic charts a new course in health care by developing tomorrow s curative therapies and launching groundbreaking surgical procedures. The pandemic of chronic diseases continues to spread as conventional medical standards and practices often fail to address the root causes of major health conditions. Newfound knowledge instilled through Regenerative Medicine offers innovative strategies for replacing, renewing, and restoring the structure and function of organs, tissues, and cells in patients bodies. Unlike any other medical approach, Regenerative Medicine transcends the confines of traditional treatments to transform health care by developing cures for patients with limited or no options. Because Regenerative Medicine is the forefront of health care, we ask our benefactors to serve as co-visionaries who imagine the unimaginable. MC7136